The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia
- PMID: 11040887
- DOI: 10.1192/bjp.177.3.252
The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia
Abstract
Background: The identification of fluctuating confusion is central to improving the differential diagnosis of the common dementias.
Aims: To determine the value of two rating scales to measure fluctuating confusion.
Method: The agreement between the clinician-rated scale and the scale completed by a non-clinician was determined. Correlations between the two scales were calculated; variability in attention was calculated on a computerised cognitive assessment and variability in delta rhythm on an electroencephalogram (EEG).
Results: The Clinician Assessment of Fluctuation and the computerised cognitive assessment were completed for 155 patients (61 Alzheimer's disease, 37 dementia with Lewy bodies, 22 vascular dementia, 35 elderly controls). A subgroup (n = 40) received a further evaluation using the One Day Fluctuation Assessment Scale and an EEG. The two scales correlated significantly with each other, and with the neuropsychological and electrophysiological measures of fluctuation.
Conclusions: Both scales are useful instruments for the clinical assessment of fluctuation in dementia.
Similar articles
-
Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia.Neurology. 2000 Apr 25;54(8):1616-25. doi: 10.1212/wnl.54.8.1616. Neurology. 2000. PMID: 10762503 Clinical Trial.
-
Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct.J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):382-7. doi: 10.1136/jnnp.2002.002576. J Neurol Neurosurg Psychiatry. 2004. PMID: 14966152 Free PMC article.
-
EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.Brain. 2008 Mar;131(Pt 3):690-705. doi: 10.1093/brain/awm322. Epub 2008 Jan 17. Brain. 2008. PMID: 18202105
-
Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.J Clin Psychiatry. 2001;62 Suppl 21:19-22. J Clin Psychiatry. 2001. PMID: 11584983 Review.
-
Electroencephalographic markers in dementia.Acta Neurol Scand. 2017 Apr;135(4):388-393. doi: 10.1111/ane.12638. Epub 2016 Jul 18. Acta Neurol Scand. 2017. PMID: 27430350 Review.
Cited by
-
Neuropsychological Assessment for Early Detection and Diagnosis of Dementia: Current Knowledge and New Insights.J Clin Med. 2024 Jun 12;13(12):3442. doi: 10.3390/jcm13123442. J Clin Med. 2024. PMID: 38929971 Free PMC article. Review.
-
Cognitive fluctuations in connection to dysgraphia: a comparison of Alzheimer's disease with dementia Lewy bodies.Clin Interv Aging. 2015 Mar 26;10:625-33. doi: 10.2147/CIA.S79679. eCollection 2015. Clin Interv Aging. 2015. PMID: 25848239 Free PMC article.
-
Benefit-risk considerations in the treatment of dementia with Lewy bodies.Drug Saf. 2002;25(7):511-23. doi: 10.2165/00002018-200225070-00005. Drug Saf. 2002. PMID: 12093309 Review.
-
Pay attention to the basal ganglia: a volumetric study in early dementia with Lewy bodies.Alzheimers Res Ther. 2019 Dec 21;11(1):108. doi: 10.1186/s13195-019-0568-y. Alzheimers Res Ther. 2019. PMID: 31864422 Free PMC article.
-
Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer's disease.Hum Brain Mapp. 2016 Mar;37(3):1254-70. doi: 10.1002/hbm.23100. Epub 2015 Dec 26. Hum Brain Mapp. 2016. PMID: 26705763 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical